UBS Group’s General Moly, Inc. GMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-28,525
| Closed | -$3K | – | 9185 |
|
|
2020
Q3 | $3K | Buy |
28,525
+27,025
| +1,802% | +$5K | ﹤0.01% | 7612 |
|
|
2020
Q2 | $0 | Sell |
1,500
-6,195
| -81% | -$1.23K | ﹤0.01% | 8632 |
|
|
2020
Q1 | $1K | Sell |
7,695
-53,987
| -88% | -$11K | ﹤0.01% | 7885 |
|
|
2019
Q4 | $14K | Buy |
61,682
+54,757
| +791% | +$14.2K | ﹤0.01% | 7119 |
|
|
2019
Q3 | $1K | Sell |
6,925
-30,171
| -81% | -$7.54K | ﹤0.01% | 7905 |
|
|
2019
Q2 | $13K | Sell |
37,096
-8,334
| -18% | -$2.39K | ﹤0.01% | 6923 |
|
|
2019
Q1 | $10K | Sell |
45,430
-41,873
| -48% | -$10.3K | ﹤0.01% | 6847 |
|
|
2018
Q4 | $19K | Buy |
87,303
+74,324
| +573% | +$16.9K | ﹤0.01% | 6853 |
|
|
2018
Q3 | $5K | Sell |
12,979
-13,712
| -51% | -$5.36K | ﹤0.01% | 7527 |
|
|
2018
Q2 | $11K | Buy |
26,691
+5,479
| +26% | +$2.17K | ﹤0.01% | 7099 |
|
|
2018
Q1 | $8K | Buy |
21,212
+19,712
| +1,314% | +$7.72K | ﹤0.01% | 7030 |
|
|
2017
Q4 | $0 | Sell |
1,500
-38,862
| -96% | -$12.4K | ﹤0.01% | 8238 |
|
|
2017
Q3 | $16K | Buy |
40,362
+38,862
| +2,591% | +$16.4K | ﹤0.01% | 6623 |
|
|
2017
Q2 | $1K | Sell |
1,500
-29,915
| -95% | -$10.3K | ﹤0.01% | 7555 |
|
|
2017
Q1 | $16K | Buy |
31,415
+14,543
| +86% | +$6.99K | ﹤0.01% | 6328 |
|
|
2016
Q4 | $4K | Buy |
16,872
+4,352
| +35% | +$1.13K | ﹤0.01% | 7358 |
|
|
2016
Q3 | $4K | Buy |
+12,520
| New | +$3.98K | ﹤0.01% | 7228 |
|
|
2016
Q2 | – | Sell |
-22,808
| Closed | -$8K | – | 8096 |
|
|
2016
Q1 | $8K | Buy |
22,808
+14,343
| +169% | +$3.42K | ﹤0.01% | 6809 |
|
|
2015
Q4 | $2K | Buy |
+8,465
| New | +$2.31K | ﹤0.01% | 8057 |
|
|
2015
Q3 | – | Sell |
-12,423
| Closed | -$9K | – | 8772 |
|
|
2015
Q2 | $9K | Sell |
12,423
-11,104
| -47% | -$7.9K | ﹤0.01% | 7566 |
|
|
2015
Q1 | $12K | Buy |
23,527
+13,527
| +135% | +$6.9K | ﹤0.01% | 7514 |
|
|
2014
Q4 | $6K | Buy |
+10,000
| New | +$5.63K | ﹤0.01% | 8881 |
|
Other funds holding GMO
UBS Group's GMO Position: Q4 2020 in Review
UBS Group sold out of General Moly, Inc. (GMO) in Q4 2020, closing a stake of 28,525 shares — an estimated $3K sold.
UBS Group first reported a position in GMO in Q4 2014 and held it in 22 quarters. The position peaked at $19K in Q4 2018. 7 funds tracked by Wall St. Rank hold GMO as of Q4 2020.
- UBS Group reported no remaining General Moly, Inc. position as of Q4 2020 after selling out during the quarter.
- UBS Group sold 28,525 General Moly, Inc. shares in Q4 2020, an estimated $3K.
- UBS Group first reported a position in General Moly, Inc. in Q4 2014 and held it in 22 quarters.
- UBS Group's General Moly, Inc. position peaked at $19K in Q4 2018.
- 7 funds tracked by Wall St. Rank held General Moly, Inc. as of Q4 2020.
Based on UBS Group's 13F filing for Q4 2020, filed 11 Feb 2021.